GOT1 and retinal degeneration: Ex vivo studies have demonstrated that the retina relies on aspartate aminotransferases for amino acid metabolism (13, 14), and GOT1 has been shown to be a biomarker of early retinal degeneration in retinitis pigmentosa (15), suggesting a possible target for therapeutic approaches.